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Abstract
Issue: Indonesia has an explosive HIV/AIDS epidemic starting from the beginning of this century,
and it is in process to build its response. Reported AIDS cases doubled from 2003 – 2004, and
approximately 54% of these cases are in people who inject drugs.
Setting: Indonesia is the 4th largest country in population in the world, a predominantly Muslim
country with strong views on drug users and people living with HIV/AIDS. Globally speaking,
Indonesia has one of the most explosive epidemics in recent years.
The project: IHPCP (Indonesia HIV/AIDS Prevention and Care Project) is a joint support project
(primarily AusAID-based) that works in partnership with the Government of Indonesia. IHPCP has
been a key player of in the country's response, particularly pioneering NSP; stimulating and
supporting methadone programs, and being key in promoting ARV for people who currently inject
drugs. The project works via both the public health system and NGOs.
Outcomes: It is still early to measure the impact of current interventions; however, this paper
describes the current status of Indonesia's response to the HIV/AIDS crisis among people who
inject drugs, and analyses future challenges of the epidemic in Indonesia.
I. Background
According to the last UNAIDS report on the global HIV/
AIDS epidemic, the core expansion of the HIV/AIDS epi-
demic (absolute number of cases reported) is currently
based on injecting drug use in Asia and Eastern Europe
[1]. India recently achieved the biggest number of
reported AIDS cases of any country globally, however the
two major epidemics in Asia – mainly driven by injecting
drug use – are in China and Indonesia. This paper reports
the current situation in Indonesia by the end of 2006, and
how the national response to this crisis is being built by
the Indonesian government, civil society and external
partners.
Indonesia is a country of approximately 17,000 islands,
with the fourth largest population in the world. It is a pre-
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dominantly Muslim country with strong views on drug
users, sex (use of condoms) and people living with HIV/
AIDS.
After 32 years dominated by a military dictatorship, the
democratization process is very recent, having started in
1998. As part of this process, decentralization of power
and budgets, and consequently decentralization of the
responsibilities on public policies and governance, has a
clear impact on the public health system. As time passes,
cities, districts and provinces are addressing the alignment
of responsibilities in public health matters. The decentral-
ization of the response to the HIV/AIDS epidemic is an
ongoing process with increasing responsibilities shared
among different levels of government.
The epidemic of HIV/AIDS in Indonesia reported its first
case of AIDS in 1987. The first reported AIDS case among
people who inject drugs (IDU) was in 1995. Since then,
IDUs have constituted a major component of the coun-
try's epidemic [2]. According to the Centre for Disease
Control (CDC) of the Ministry of Health of Indonesia,
reported AIDS cases doubled from 2003 – 2004, and
approximately 80% of the new cases in the last two years
are among people who inject drugs. Cumulatively, trans-
mission of HIV related to the use of injectable drugs
accounts for 54% of the total AIDS cases in the country
[3]. National estimates indicate that the number of people
living with HIV/AIDS ranges from 165,000 to 216,000
[4]. Widespread, free access to an HIV test is a recent phe-
nomenon; the logistics of the system is still being worked
out. Available data is not accurate; there is as well the need
to increase quality of data collection and flux of the infor-
mation.
Currently, there are many bodies of the Government play-
ing a role in the control of the HIV/AIDS epidemic, prima-
rily the KPA or the National Commission on AIDS, which
has been attached to the Presidential Cabinet from July
2006. With a recently empowered strong leadership, KPA
is in the process of recruitment to build their internal team
with some of the best staff in the field of HIV/AIDS in the
country and has a very promising role in response leader-
ship. KPA is not involved in policy implementation, but
rather responsible for formulating policies, and works
mainly with international sources – centred on DFID, the
British Cooperation – via partnership funds, which are
administrated by UNDP. UNAIDS is the multilateral
organization that provides technical support to KPA.
The Ministry of Health is responsible for implementating
the response to the HIV/AIDS epidemic, comprised of
four departments. The Pharmacy Department is responsi-
ble for all medications. The Centre for Diseases Control
includes the National AIDS Program which is responsible
for program development, building local human
resources and for all matters related to epidemiology. The
Department of Medical Services runs all the hospitals, the
Drug Program (including methadone clinics), and all lab-
oratories. Lastly, the Community Health Department is
responsible for the Community Public Health Centres
(Puskesmas) programs. It has been somewhat difficult to
integrate all departments in one coordinated implementa-
tion of the HIV/HIV/AIDS response. WHO is the multilat-
eral organization that works closely with the Ministry of
Health to assist the Indonesian national response.
At the national level in the harm reduction field is the
National Narcotic Board (BNN), which is attached to the
National Police. This body is also responsible for narcotic
demand and supply reduction, their primary focus. Also
related to this effort is the Ministry of Justice and Human
Rights, which runs prisons in the country and is responsi-
ble for every intervention inside the prison system.
In addition to the Indonesian government sectors, the
international community is involved in the country's
HIV/AIDS response. Indonesia received $64 million US
from the fourth round of the Global Fund with a project
whose scope contains what is required to confront the epi-
demic, including a detailed cost study build in the WHO
model (Costing Guidelines for HIV/AIDS Intervention
Strategies). The Ministry of Health, through the Centre for
Disease Control, leads the implementation of the Global
Fund project. Unfortunately in Indonesia, administration
of the Global Fund sources has led to a "D" classification,
with results below expectations [5]. National and interna-
tional experts in the country agree that the lack of good
reporting process could be influential in establishing this
classification. In addition to the Global Fund, DFID,
USAID, AusAID and KFW are working in Indonesia in the
field of HIV/AIDS. WHO, UNAIDS and recently UNODC,
among other UN agencies, also have a strong influence on
the response thus far. Other international agencies have
minor influence in specific aspects of the response in
Indonesia.
In addition to the efforts from the Indonesian national
government and international partners, there are local
responses organized in several provinces and cities, in
conjunction with the decentralization process already
mentioned. Commitments are different based on the spe-
cific local history and importance of the epidemic, as well
as the political climate of the various local governments.
To complete this complex framework, Non-Governmen-
tal Organizations (NGOs) were involved at the onset and
are still crucial in the Indonesian response to the HIV/
AIDS epidemic.Harm Reduction Journal 2007, 4:9 http://www.harmreductionjournal.com/content/4/1/9
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With permeable borders in its 17,000 islands, geographi-
cally close to the Golden Triangle, and as well not greatly
distant from Afghanistan, since the late 90s, Indonesia has
become a great market for heroin, and currently also a ris-
ing market for amphetamines. In its 2005 report, the
National Narcotics Board indicated that there are 3.2 mil-
lion drug users in Indonesia of which 25% are heavily
addicted and injecting drugs [6]. Still, according to BNN,
the trends of drug use are measured by drug treatment
admissions in hospitals, admissions in rehabilitation cen-
tres, drug seizures, prisons for drug offences, and injecting
drug users reported by the Ministry of Health as AIDS
cases. According to the sum total of this information, mar-
ijuana is the number one drug of abuse, followed by her-
oin, amphetamine type stimulants (ATS), hashish and
cocaine. There is an increased availability of night drugs
such as ecstasy also available in Indonesia. Poly-drug use,
sedative hypnotic drugs and drugs of inhalation are also
being reported. As already mentioned, BNN manages
demand reduction, which for Indonesia includes: "preven-
tion (family based, school based, community based and work-
place based) treatment and rehabilitation activities in both
public, NGO, and private facilities, employing various modali-
ties. Supply Reduction Strategies are implemented through
more intensive eradication of cannabis cultivation, intensive
investigations and raids of clandestine manufacturers and
applying strict airport and seaport interdictions" [7]. Burnet
Institute's Centre for Harm Reduction in collaboration
with the Turning Point Alcohol and Drug Centre con-
ducted a recent situational analysis in Indonesia (as well
as other countries in Asia) on behalf of the Australian
National Council on Drugs and found similar informa-
tion on drugs, drug supply and demand reduction [8].
Under the Indonesian legislation, the use of drug is crim-
inal (this is also true of possession) and trafficking is pun-
ishable by the death penalty. The strict criminalization of
drug use behaviours has made it difficult to reach inject-
ing drug users for health care services and harm reduction
programs.
At the early stage of the epidemic among drug users in the
late 90's, the response was dominated by NGOs sup-
ported by international aid agencies such as USAID and
AUSAID [9]. Local governments were not showing the
commitment needed for the response while the central
government was just beginning to get more exposure to
the problem and to harm reduction approaches.
Regarding harm reduction, the first recorded NGO organ-
izing harm reduction services was Yayasan Hati-hati (Bali-
based) in 1998. Since then, more organizations developed
in many parts of the country, the majority founded after
the beginning of the 21st century. All of these organiza-
tions are made up of people with previous experience in
the drug field (the majority former drug users) to address
the AIDS epidemic among IDUs. Yet their connection
within the AIDS social movement has been weak. Mean-
while, these organizations had modestly better connec-
tions with the international platform, especially more
recently. Their primary source of financial support is inter-
national donors (mainly bilateral projects – in particular,
IHPCP/AusAID and FHI/USAID), with the exception of a
few organizations with diversified donors and partners.
Interestingly, their activities have not put much empha-
size on activism, and have not exhibited much responsi-
bility in fighting for the rights of drug users (e.g.,
guaranteed access to ARV, better laws, better policies and
other basic issues of global human rights NGOs). Such
advocacy is being promoted by IHPCP and more recently
by the Open Society Institute as well.
Thus, despite the growing commitment by all players
especially in recent years, all are convinced that the
response to the HIV/AIDS epidemic so far is insufficient
for the size of the problem. The dominance of NGOs has
proved ineffective in scaling up efforts of AIDS services,
particularly for IDUs.
In response to the problem, IHPCP's latest commitment
in harm reduction has been to include the public health
system in the service of AIDS to drug users and the
empowerment of drug users as Indonesian citizens for
universal access to health care.
II- Description of the response so far and the role 
of IHPCP
The Indonesian response to the HIV/AIDS crisis among
people who inject drugs is still modest. There is a clear
consensus among stakeholders of an urgent need to scale
up the response to the epidemic. In total, 41 NGOs are
working in the field of harm reduction. Among these, 16
are conducting needle and syringe program projects, tar-
geting 4,500 people who inject drugs on a monthly basis,
all but one of these 16 NGOs supported by IHPCP. The
other 25 organizations started modest syringe distribu-
tion after the second semester of 2006 with funding from
the Partnership and the Global Fund, and they are part-
ners of Family Health International in Indonesia. Besides
NGOs, public health centres (Puskesmas) are also con-
ducting harm reduction activities, including needle and
syringe exchange. In July 2005 only one Puskesmas from
Jakarta was developing harm reduction activities in Indo-
nesia. By 2006, this had increased to 65. IHPCP and the
local AIDS commissions are sharing the cost of these facil-
ities for one year, with the commitment that future costs
will be fully borne by the government. In September
2006, the City of Bandung Public Health Department in
West Java, with their own funds, opened another 9 NSP in
Public Health Centres. IHPCP provided technical support
for planning and staff capacity building. So the currentHarm Reduction Journal 2007, 4:9 http://www.harmreductionjournal.com/content/4/1/9
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total of NSP slots in Indonesia by December of 2006 is
actually 115.
These public health centres are targeting to reach another
23,000 people who inject drugs. The interaction of public
health services and non-governmental organizations is
the key element of interventions to scale up the response
in the country. The role of the Public Health Centres, espe-
cially in the capital region of Jakarta and West Java (two of
the main provinces of Indonesia) is to lead the response
and use the infrastructure of the health system to scale the
response to the level of the epidemic. The expansion was
based on a successful experience conducted in the City of
Sao Paulo, Brazil, from 2001 to the present [10]. Today
the aim of the current projects is to achieve treatment of
30% of the injecting drug users in the country but because
most efforts are new projects, the coverage is approxi-
mately 10% of the target. The scale-up proposed by KPA
aims to achieve 70% of IDUs by 2010.
At the beginning of 2005 (after almost 7 years of the first
NEP in Indonesia), most of the NEPs were still focused on
the distribution/exchange of syringes only. Our effort after
2005 was to change the intervention for a comprehensive
prevention package which includes, besides the sterile
syringes, condoms, alcohol swabs, IEC (information, edu-
cation, communication) material; projects conducted
mainly on an outreach basis with a strong connection to
the health system for referral in basic health care, drug
treatment (highlighting methadone), and support and
treatment for drug users at risk for HIV/AIDS.
Drug treatment in Indonesia is primarily based on drug
free clinics for detoxification and rehabilitation, normally
conducted by mental hospitals, NGOs or therapeutic
communities. There is no official compulsory treatment
in Indonesia. Buprenorphine is still expensive and not
widely available. So far, approximately 300 doctors
(mostly private doctors) across the country are certified to
prescribe Buprenorphine. As well, anecdotal reports from
IDUs in several provinces including Bali, West Java and
other regions indicate a high rate of injecting Buprenor-
phine as heroin becomes scarcer in the market. Metha-
done was established first in Indonesia in 2003 by WHO
and the Ministry of Health in two pilot projects, one in
Jakarta and one in Bali. These two pilots together existed
until the end of 2005, serving a population of approxi-
mately 300 drug users. Since 2004, IHPC has supported
the main expenses of these two projects. Under the polit-
ical influence of BNN in June 2005 (during the Anti-Drug
World Day), Indonesian President Suscilo Bambang
Yudoyono visited one of the clinics and announced a pub-
lic program to expand methadone use based on its success
so far. The expansion of methadone really started in 2006.
By the end of 2006 there were 7 clinics serving approxi-
mately 1,000 clients. KPA's plan is to increase the number
of drug users treated to more than 50,000 by 2010.
The work in prison is another front of harm reduction
work in Indonesia. In June 2005, the Ministry of Justice
and Human Rights launched the National Strategy for Pre-
vention and Control of HIV/AIDS and Drug Abuse in
Indonesian Correction and Detention Centres, for the
period 2005–2009 [11]. The document detailing this pro-
gram, the first of its kind in Asia, provides the framework
for the work of prevention, care, support, and treatment of
the HIV/AIDS epidemic inside the prison system. It was
constructed with intensive input from IHPCP and other
donors as well. Currently, only a few of the 396 prisons in
Indonesia provide CST and HIV prevention; however
some potentially effective demonstration projects are
ongoing. The gold standard is the Balinese prison of Ker-
obokan where distribution of bleach and condoms for
prisoners, as well as treatment with methadone and ARV
are made available [12]. The central issue on the prison
response to HIV/AIDS epidemic is the urgent need of
increasing these interventions to address the sizeable
problem. KPA's strategic plan is to cover 95 prisons by
2010, 20 of them with comprehensive programs like the
one in Bali.
The legal basis for the Indonesian Response to HIV/AIDS
among people who inject drugs is for the most part based
on policy. Legislation in Indonesia is under debate to
allow programs to assist in controlling the epidemic.
There is no law against harm reduction in Indonesia, but
prejudicial interpretation and misinterpretation of the
current laws (all in effect before the HIV/AIDS epidemic)
have resulted in many constraints, primarily in the realm
of prevention. The Sentani Commitment signed in Janu-
ary of 2004 by the Head of the National AIDS Commis-
sion and many other authorities in Indonesia – and re-
edited clearly delineating needle and syringe programs, as
well as methadone programs – in June of 2005 is the main
document supporting harm reduction activities in the
country [13]. Memorandums of Understanding signed
between ministers are also important support documents,
such as those signed by the National AIDS Commission
and the National Bureau on Narcotics. Public statements
from authorities, including the President and the Vice-
President of Indonesia, clearly supported harm reduction
programs as well. Local authorities, such as the Vice-Gov-
ernors of DKI Jakarta, West Java and Bali, but not limited
to these officials, are publicly also supportive of harm
reduction, including the commitment of their provinces'
budgets to support the scaling up of the response. Some
political resistance has arisen from some sectors of the
police that prefer to maintain a focus on law enforcement,
even though this strategy has previously been shown to
fail. Some religious leaders are more resistant to the pro-Harm Reduction Journal 2007, 4:9 http://www.harmreductionjournal.com/content/4/1/9
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motion of safe sex than to the promotion of safer use of
drugs.
Advocacy of the police is the most difficult part of the job.
Indonesia has a history of militarization of the street
police that is still currently in effect. Police officers are
underpaid, under-trained and under-equipped in Indone-
sia. As in many other countries, the police are susceptible
to corruption and the use of unnecessary force. Politicized
and influential, positions often change and sometimes all
expenditures related to a specific advocate decrease or
even disappear as a result of constant changes and are sub-
sequently re-introduced. This can make for noticeable cost
inefficiency.
The concept of universal access to AIDS treatment is new
to Indonesia. The policy of free and universal access for
ARV was implemented in 2004. According to the 3 × 5 ini-
tiative of WHO, Indonesia was recorded as having 10,000
people with AIDS (in need of ARV) by the end of 2005, of
which 4,000, or 40% of the target, had been treated with
ARV.
In Indonesia, national production of ARV is done by
Kimia Farma, an Indonesian Governmental Pharmaceuti-
cal Company contracted by the Ministry of Health. First
line medications produced in the country are Zidovudine,
Nevirapine and Lamivudine. Indonesia has also made
available other ARVs by import: Efavirenz; Stavudine and
lopinavir + ritonavir - Kaletra [14] and gradually is
increasing the choices. ARV is free of charge in the univer-
sal access spirit since the end of 2004; however ARV free
of charge does not mean easy and free access. A CD4
account is still paid by the client with a cost of around US$
13.00, an expensive blood test for Indonesians. Doctors
still charge for the cost of consultation. It should be noted
that about 20% of Indonesians are subsidized by the gov-
ernment based on poverty; thus, they obtain free health
care, but 80% of the population still pays for health care.
A recent global review estimates that in Indonesia, people
who inject drugs are about 31% of the people treated with
ARV [15]. Thus, of the entire population of individuals
who use injected drugs needing ARV treatment, about
25% are in treatment. This data takes into account equal
likelihood for current or former injecting drug users. If we
also consider the personal decisions of doctors who mis-
understand the need for involving current injecting drug
users in needed ARV treatment, this will likely worsen this
scenario.
By 2006 IHPCP had attempted to stimulate among doc-
tors in Indonesia the potential benefit of WHO and sev-
eral other organizations to increase the number of current
injecting drug users for ARV treatment [16]. From the pre-
viously mentioned 65 Public Health Centres are already
actively engaged in NSP, 11 received training for imple-
mentation of VCT and ARV availability in community
health centre settings. The joint initiative from IHPCP
with the Indonesian Association of Doctors working with
AIDS (PDPAI – Perhimpunan Dokter Peduli AIDS Indo-
nesia) is also helping to promote the education of doctors
in the country for universal access.
Formally, Indonesia is the only country in Asia that does
not restrict people who inject drugs (including current
users) from access to ARV treatment, and it is one of the
few countries that produce the first line of ARVs for its
own consumption. The KPA strategic plan has the provi-
sion to extend care, support and treatment of people who
inject drugs to a total of 75 Public Health Centres (Puskes-
mas) by 2010, doubling the current possibilities for
access.
Drug user participation is also currently a key element of
the growing Indonesian response to the epidemic. Besides
many NGOs made up of current and former drug users,
two networks highlight the key participation of drug
users. Jangkar is network of organizations working in the
field of AIDS, and IDUSA is a Drug Users Individual Net-
work. Both are obtaining strong support for their activities
from IHPCP and other partners and are gradually being
included in all important governmental meetings and
decisions. Their agenda includes both the controlling of
the HIV/AIDS epidemic and the key issue of the human
rights of drug users.
The current scenario seems challenging. But realizing that
as recently as two to three years earlier the current infra-
structure for HIV/AIDS treatment was not in place, it's fair
to say that currently, all the components for a compre-
hensive response are in place in Indonesia. The remain-
ing question is how to expand this scenario,
simultaneously guaranteeing the quality of interventions.
III- Discussion and conclusion
Indonesia, the third biggest country in Asia, is facing an
explosive epidemic driven by people who inject drugs.
Even in a very inhospitable political and social environ-
ment, Indonesia is building a comprehensive response
spearheaded by the commitment of the Indonesian gov-
ernment, province governments, civil society and interna-
tional agencies. The response among people who inject
drugs is being included in the public health system as a
key strategy to push for the needed expansion of services.
The role of the local governments is crucial, including
their political and budget commitments, as a strong step
in the sustainability of the response. The clear direction of
the key interventions to address the HIV/AIDS epidemic
that has affected Indonesia for the last 25 years is anotherPublish with BioMed Central    and   every 
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important result. The clear focus on NSP, methadone, and
care, support and treatment of people who inject drugs
speaks to what needs to be done to address the epidemic.
Initiatives from Indonesia such as the program to supply
methadone inside prisons, and the promotion of ARV for
current injecting drug users, are being perceived as the
gold standard for all of Asia, a continent severely impacted
by the HIV/AIDS epidemic. There is a long way to go in
Indonesia to significantly impact the epidemic and thus
celebrate the saving of thousands of lives, but the bases are
very well established.
As UNAIDS head Peter Piot stated: "...we need to do more
of the wonderful things we have been doing so far".
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